ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,886.42
-0.29%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neuronetics Inc (STIM)

  7. Neuronetics Inc (STIM) News

STIM

Neuronetics (STIM)

Neuronetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STIM
DateTimeSourceHeadlineSymbolCompany
15/05/202421:32GlobeNewswire Inc.Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsNASDAQ:STIMNeuronetics Inc
08/05/202406:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
07/05/202421:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
07/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
07/05/202421:30GlobeNewswire Inc.Neuronetics Reports Record First Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
04/05/202406:30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
01/05/202422:31GlobeNewswire Inc.NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness MonthNASDAQ:STIMNeuronetics Inc
24/04/202406:30GlobeNewswire Inc.Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
10/04/202422:31GlobeNewswire Inc.New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalNASDAQ:STIMNeuronetics Inc
28/03/202407:30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
25/03/202423:30GlobeNewswire Inc.NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
08/03/202400:22GlobeNewswire Inc.Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care NetworkNASDAQ:STIMNeuronetics Inc
07/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/03/202423:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/03/202423:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/03/202423:30GlobeNewswire Inc.Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
02/03/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
02/03/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
01/03/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
01/03/202408:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
29/02/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
29/02/202408:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
29/02/202408:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
28/02/202409:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
27/02/202409:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
27/02/202408:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
24/02/202408:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
23/02/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
23/02/202408:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
21/02/202407:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
 Showing the most relevant articles for your search:NASDAQ:STIM

Your Recent History

ASX
ORIKOE
BIT
UC71MM
Unicredit Bank
ASX
MQGBOR
NASDAQ
ARWAR
TSX
5533
Elitz
NASDAQ
AHPI
Allied Healthcare Products
COIN
SDUST
Stader
LBNK
EXNUSDT
EXENO COIN
LSE
48XE
Roy.bk.ca. 2039
BIT
I10035
IT0005590374 20240902 4.7
LSE
FL27
Int.fin. 25
EU
ZSG3D
Euronext Eurozone SBT 15...
GATE
FORETH
The Force Token [ForTube]
TSXV
BZ
Benz Mining
EU
P678S
P678S
LSE
0FP9
Banca Profilo
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved